Evidence map›Paper›PMID 42212168›Full record

ArticleFrontiers in bioengineering and biotechnology2026

Comparative biodegradation of functionalized graphene oxide nanosheets by myeloperoxidase and neutrophil extracellular traps.

Mohsen Bahmani, Asma Gholami, Marziyeh Ghaeidamini, Zhejian Cao, Mohammad Reza Gharib-Zahedi, Pallab Sanpui, Elin K Esbjörner, Leif A Eriksson, Ivan Mijakovic, Shadi Rahimi

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mohsen Bahmani *Division of Systems and Synthetic Biology, Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.
Asma Gholami *Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.
Marziyeh GhaeidaminiDivision of Molecular Bioscience, Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.
Zhejian CaoDivision of Systems and Synthetic Biology, Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.
Mohammad Reza Gharib-ZahediDepartment of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.
Pallab SanpuiDepartment of Biotechnology, Birla Institute of Technology and Science, Dubai, United Arab Emirates.
Elin K EsbjörnerDivision of Molecular Bioscience, Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.
Leif A ErikssonDepartment of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.
Ivan MijakovicDivision of Systems and Synthetic Biology, Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.
Shadi RahimiDivision of Systems and Synthetic Biology, Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Graphene oxide (GO) nanosheets have attracted significant interest as potential carriers for drug delivery due to their unique physicochemical properties and large surface area. However, concerns regarding their cytotoxicity and biodegradability must be addressed before clinical translation. In this study, we aimed to evaluate the biocompatibility and biodegradation of GO functionalized with polyethylene glycol (PEG) and polyethyleneimine (PEI), two commonly used polymers in biomedical applications. Method: The interactions of GO, GO-PEG, and GO-PEI with granulocyte-like cells were investigated to determine their effects on cell viability and their susceptibility to immune-mediated degradation. Biodegradation of the materials was assessed using Raman spectroscopy after exposure to granulocyte-like cells, neutrophil extracellular traps (NETs), and myeloperoxidase (MPO), a key enzyme present in NETs. In addition, circular dichroism (CD) spectroscopy was used to evaluate structural changes in MPO upon interaction with the materials, and molecular dynamics simulations were performed to investigate the interaction of hypochlorous acid (HOCl), the catalytic product of MPO, with GO and its functionalized derivatives. Results and discussion: The results showed that functionalization with PEG or PEI significantly improved cell viability compared with pristine GO. Although GO was structurally modified by granulocyte-like cells, NETs, and MPO, GO-PEG did not show significant degradation under these conditions. In contrast, GO-PEI was susceptible to structural modification by both NETs and MPO. CD analysis indicated that MPO maintained a more stable secondary structure in the presence of GO-PEI compared with GO or GO-PEG under oxidative conditions, suggesting that MPO-generated HOCl may play a key role in GO-PEI degradation. Molecular dynamics simulations further demonstrated stronger interaction and retention of HOCl in GO-PEG and GO-PEI systems compared with pristine GO, indicating an enhanced interaction between oxidants and the functionalized materials. Overall, these findings demonstrate that polymer functionalization significantly influences the biocompatibility and immune-mediated structural modification of GO. Importantly, this study provides new mechanistic insights into how PEG and PEI modifications affect MPO-driven oxidative degradation pathways of graphene oxide-based nanomaterials. These results highlight GO-PEI as a biodegradable and biocompatible candidate for future biomedical and drug delivery applications.

Indexed as

biodegradationgraphene oxidemolecular dynamics simulationsneutrophil extracellular trapsneutrophils

Identifiers

PMID42212168
PMCPMC13213391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.